Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer

Por Jiang Chen MD, Yangjie Liao MD, Rui Li MD, Mingjiang Luo MD, Guanlin Wu MD, Ruirong Tan PhD, Zhihong Xiao MD
Publicado em 2022-05-01

Targeted Protein Degradation: An Important Tool for Drug Discovery for “Undruggable” Tumor Transcription Factors

Por Mengyuan Dai PhD, Sridhar Radhakrishnan PhD, Rui Li PhD, Ruirong Tan PhD, Kuo Yan PhD, Gang Fan PhD, Miao Liu PhD
Publicado em 2022-04-01